Additionally, we have identified eight new adverse events (AE) which include ketosis, euglycemic diabetic ketoacidosis, pancreatic cancer, sixth cranial nerve palsy, hyperglycemic hyperosmolar nonketotic syndrome, elevated glycated hemoglobin, positional dizziness, and belching
There have also been instances where patients experienced acute kidney injury and renal insufficiency while on these medications
So many med spas are jumping on the wellness bandwagon, encouraging treatments that have little or no science
They typically cannot be combined with government coverage such as Medicare
The FDA is evaluating reports of suicidal thoughts or behaviors in patients taking these medications, though a causal relationship has not been established
A glucagon-like peptide-1 receptor agonist, semaglutide, mimics the action of a natural hormone called GLP-1, reducing blood sugar levels by stimulating insulin secretion and reducing glucagon secretion